PROF vs ROL · rev $10.7M vs P/E 41, rev $3.39B
Profound Medical Corp (PROF) versus Rollins Inc (ROL) — a side-by-side from cached financials, not a winner call.
Profound Medical Corp (PROF) is a medical devices company listed on NASDAQ.
Rollins Inc (ROL) is a personal services company listed on NYSE.
Latest reported PROF revenue for 2024-12-31 was $10.7M. Net income was -$27.8M. Revenue was up 48.4% from 2023-12-31 to 2024-12-31. PROF currently screens at market cap $238.7M.
Latest reported ROL revenue for 2024-12-31 was $3.39B. Net income was $466.4M. Revenue was up 10.3% from 2023-12-31 to 2024-12-31. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
PROF currently screens at market cap $238.7M. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
Not investment advice. Open the PROF and ROL stock pages for the full models.
Not investment advice.